Literature DB >> 27938787

Surveillance of patients with hereditary gastrointestinal cancer syndromes.

Leticia Moreira1, Antoni Castells2.   

Abstract

Gastrointestinal cancers are among the most frequent tumors. Although most cases are sporadic, up to 5-6% develops in the context of gastrointestinal hereditary syndromes. These entities have specific characteristics and often a germline mutation identified, thus allowing performing genetic counseling. This review summarizes the most common gastrointestinal hereditary syndromes, focusing on the surveillance recommendations.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; Gastric cancer; Germline mutation; Hereditary cancer syndrome; Pancreatic cancer; Prevention; Surveillance

Mesh:

Year:  2016        PMID: 27938787     DOI: 10.1016/j.bpg.2016.10.004

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  4 in total

Review 1.  Resolving gastric cancer aetiology: an update in genetic predisposition.

Authors:  Paul C Lott; Luis G Carvajal-Carmona
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-12

2.  Germline mutations in hereditary diffuse gastric cancer.

Authors:  Hao Zhang; Mengmeng Feng; Yi Feng; Zhaode Bu; Ziyu Li; Shuqin Jia; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2018-02       Impact factor: 5.087

3.  Evaluation of confocal endoscopic microscopy for detection of early-stage gastric cancer in hereditary diffuse gastric cancer (HDGC) syndrome.

Authors:  Samantha Ruff; Bryan Curtin; Martha Quezado; Theo Heller; Christopher Koh; Seth M Steinberg; Maureen Connolly; Jonathan M Hernandez; Jeremy L Davis
Journal:  J Gastrointest Oncol       Date:  2019-06

4.  Enhanced endoscopic detection of occult gastric cancer in carriers of pathogenic CDH1 variants.

Authors:  Bryan Franklin Curtin; Lauren Ann Gamble; Samuel Ali Schueler; Samantha Marilyn Ruff; Martha Quezado; Markku Miettinen; Grace-Ann Fasaye; Monica Passi; Jonathan Matthew Hernandez; Theo Heller; Christopher Koh; Jeremy Lee Davis
Journal:  J Gastroenterol       Date:  2020-11-18       Impact factor: 6.772

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.